Bone Adhesive

  • We’re heading to the ECVS Congress in Antwerp!

    ,

    We’re heading to the ECVS Congress in Antwerp! PBC BioVet is proud to participate in the European College of Veterinary Surgeons (ECVS) Congress from July 3–5 in Antwerp, Belgium. 🧬 Visit us at Booth #20 to explore how OssiVet®, our advanced bone adhesive, is transforming orthopedic surgery in veterinary practice. 💬 Learn how this innovative…

    Read More...

  • The PBC Biomed Team are delighted to celebrate the success of another exceptional #ESTROT event following our time in Leeds last week.

    ,

    The PBC Biomed Team are delighted to celebrate the success of another exceptional #ESTROT event following our time in Leeds last week. Our ‘Strengthening The Bond’ workshop on our #breakthrough bio-adhesive, OsStic®, attracted great interest and discussion, featuring a futuristic look at Bone Healing led by Prof. Thomas A. (Toney) Russell MD, including an interactive…

    Read More...

  • Join Us for the OssiVet® Webinar – April 14, 2025!

    ,

    📢 Join Us for the OssiVet® Webinar – April 14, 2025! 🦴💻 We’re excited to invite veterinary professionals to our upcoming OssiVet® Educational Webinar on Monday, April 14th, 2025. Discover how OssiVet®, our advanced orthopedic bone bioadhesive, is transforming fracture management and joint stabilization in veterinary surgery. From science to real clinical cases, we’ll cover…

    Read More...

  • PBC Biomed attend AAOS 2025

    , , ,

    PBC Biomed attend AAOS 2025 Thank you to the PBC Biomed Clinical Advisory Board for their support at the #AAOS event in San Diego last week! Dr Thomas A. (Toney) Russell MD, Dr John Tracy Watson, Dr Hassan Mir, MD, MBA and Professor Peter Giannoudis did a fantastic job of talking booth visitors through the…

    Read More...

  • OssiVet® Now Available in EU

    , ,

    OssiVet® Now Available in EU We’re excited to announce that OssiVet®, our innovative Synthetic Adhesive Bone Substitute, is now available for use in domestic companion animals for orthopedic reduction, provisional fixation, and void filling of bone fractures or defects. OssiVet® is designed to make a difference in your practice by offering: • Simplified application for…

    Read More...

  • Release Of Our Very First OssiVet® Order!

    , ,

    The PBC Biovet Operations Team has reached a significant milestone with the preparation and release of our very first OssiVet® order! OssiVet®, our innovative veterinary bioadhesive bone substitute, is designed to support advanced orthopedic care for companion animals, combining safety, efficacy, and ease of use. This landmark achievement is a testament to our team’s hard…

    Read More...

  • PBC Biomed OTA Symposium – Strengthening the Bond: Modern Biomaterials for Fracture Fixation and Bone Regeneration.

    , , , , ,

    We are delighted to announce that we will be continuing our ‘Strengthening the Bond’ education series at the Orthopaedic Trauma Association meeting in Montreal this week. Strengthening the Bond: Modern Biomaterials for Fracture Fixation and Bone Regeneration. Our global panel of surgeon advisors will discuss current hashtag#Biomaterials and their challenges, as well as plans for…

    Read More...

  • DTIF Project Consortium Progress Meeting

    , , , , , , ,

    It was fantastic to welcome the Enterprise Ireland #DTIF consortium team to our Shannon Headquarters at the start of September for a project progress meeting. Thank you to Nicholas Dunne and the DCU postgraduate team, the Dolmen Design & Innovation team, as well as Jackie FitzGerald of Enterprise Ireland for making the trip! #DTIF #disruptivetechnology…

    Read More...

  • Exciting New Hires for Biomimetic Innovations

    ,

    PBC Biomed would like to welcome our two newest members to the Biomimetic Innovations Ltd team – Quality Specialist Annmarie Donnellan (left) and Director of Operations Ann Marie Ryan (right). We are delighted to have you both on board – exciting times ahead for BMI and the development of OsStic® Technology! #newhire #operations #biomimeticinnovations #acceleratingmedicalinnovation

    Read More...

  • DTIF-funded project, OsStic® technology awarded #BreakthroughDevice designation by the FDA.

    , , , ,

    Shannon, Ireland, February 12th 2024: Irish medical device company Biomimetic Innovations Ltd, an affiliate of PBC Biomed, announced ‘Breakthrough Device’ designation from the Food and Drug Administration FDA in January, for the development of a groundbreaking new bio-adhesive bone void filler technology called OsStic®.  PBC Biomed leads a consortium for this development project, which is…

    Read More...

Connect with us on LinkedIn
Search News Items
Categories